✦ LIBER ✦

CN2 VALUE-FOR-MONEY OF PEMETREXED PLUS CISPLATIN VERSUS CISPLATIN ALONE IN THE TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA

✍ Scribed by P Davey; A Cordony; N Rajan; B Arora; N Pavlakis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of cisplatin plus pemetrexed

✍ Shukuya, Takehito; Takahashi, Toshiaki; Imai, Hisao; Tokito, Takaaki; Ono, Akira 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 398 KB

Cost-Effectiveness of Pemetrexed Plus Ci

✍ Anna Cordony; Corinne Le Reun; Antje Smala; James T. Symanowski; Jessamy Watkins 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

O-56 Symptom and quality of life advanta

✍ Boyer, M.J.; Jassem, J.; Liepa, A.M.; Symanowski, J.T.; Kaukel, E.; Denham, C.A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

PCN1 ECONOMIC IMPACT OF ADOPTING PEMETRE

✍ M Chetty; A Cordony; P Davey; K Karampela; C Le Reun; M Watt 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

P-422 Use of forced vital capacity (FVC)

✍ Pistolesi, M.; Symanowski, J.; Rusthoven, J.; Paoletti, P.; McAndrews, P.; Vogen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

1139 POSTER Economic impact of adopting

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 415 KB